Improvement of canine islet yield by donor pancreas infusion with a p38MAPK inhibitor

Transplantation

Volumn 86, Issue 2, 2008, Pages 321-329

  Ito, Taihei ^a   Omori, Keiko ^a   Rawson, Jeffrey ^a   Todorov, Ivan ^a   Asari, Sadaki ^a   Kuroda, Akio ^a   Shintaku, Jonathan ^a   Itakura, Shin ^a   Ferreri, Kevin ^a   Kandeel, Fouad ^a   Mullen, Yoko ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Canine islet autograft; Islet yield; P38MAPK inhibitor treatment; Pancreas perfusion

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; C PEPTIDE; DIMETHYL SULFOXIDE; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNIVERSITY OF WISCONSIN SOLUTION; ADENOSINE; ALLOPURINOL; CYTOKINE; ENZYME INHIBITOR; GLUTATHIONE; INSULIN; PRESERVATION SOLUTION; RAFFINOSE; UNIVERSITY OF WISCONSIN LACTOBIONATE SOLUTION; UNIVERSITY OF WISCONSIN-LACTOBIONATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; COLD ISCHEMIA; CONTROLLED STUDY; DOG; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; LASER SCANNING CYTOMETRY; MALE; NONHUMAN; ORGAN DONOR; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ENZYME ACTIVATION; METABOLISM; METHODOLOGY; ORGAN PRESERVATION; PATHOLOGY; REPERFUSION INJURY;

ADENOSINE; ALLOPURINOL; ANIMALS; APOPTOSIS; CYTOKINES; DOGS; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUTATHIONE; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RAFFINOSE; REPERFUSION INJURY;

EID: 49249111997     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817ef6c9     Document Type: Article

References (42)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Hering BJ. Achieving and maintaining insulin independence in human islet transplant recipients. Transplantation2005; 79: 1296.
3. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
4. Shapiro AM, Lakey JR, Paty BW, et al. Strategic opportunities in clinical islet transplantation. Transplantation2005; 79: 1304.
5. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant2005; 5: 2037.
6. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, et al. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J Immunol 1987; 139: 4077.
7. Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988; 37:133.
8. Movahedi B, Van de Casteele M, Caluwe N, et al. Human pancreatic duct cells can produce tumour necrosis factor-α that damages neighbouring beta cells and activates dendritic cells. Diabetologia 2004; 47:998.
9. Kotlyarov A, Neininger A, Schubert C, et al. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat Cell Biol 1999; 1: 94.
10. Tietz AB, Malo A, Diebold J, et al. Gene deletion of MK2 inhibits TNF-α and IL-6 and protects against cerulein-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1298.
11. Hegen M, Gaestel M, Nickerson-Nutter CL, et al. MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol 2006; 177: 1913.
12. Hitti E, Iakovleva T, Brook M, et al. Mitogen-αctivated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 2006; 26: 2399.
13. Smith SJ, Fenwick PS, Nicholson AG, et al. Inhibitory effect of p38 mitogen-αctivated protein kinase inhibitors on cytokine release from human macrophages. Br J Pharmacol 2006; 149: 393.
14. Matsuda T, Omori K, Vuong T, et al. Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant2005; 5: 484.
15. Blanchard JA II, Barve S, Joshi-Barve S, et al. Cytokine production by CAPAN-1 and CAPAN-2 cell lines. Dig Dis Sci 2000; 45: 927.
16. Gukovskaya AS, Gukovsky I, Zaninovic V, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-α. Role in regulating cell death and pancreatitis. J Clin Invest 1997; 100: 1853.
17. Blinman TA, Gukovsky I, Mouria M, et al. Activation of pancreatic acinar cells on isolation from tissue: Cytokine upregulation via p38 MAP kinase. Am J Physiol Cell Physiol 2000; 279: 1993.
18. Land WG. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation2005; 79: 505.
19. Kosieradzki M, Kuczynska J, Piwowarska J, et al. Prognostic significance of free radicals: Mediated injury occurring in the kidney donor. Transplantation2003; 75: 1221.
20. Raingeaud J, Gupta S, Dickens M, et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-αctivated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270: 7420.
21. Nemeth ZH, Deitch EA, Szabo C, et al. Hyperosmotic stress induces nuclear factor-kappa B activation and interleukin-8 production in human intestinal epithelial cells. Am J Pathol 2002; 161: 987.
22. Cowan KJ, Storey KB. Mitogen-αctivated protein kinases: New signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 2003; 206: 1107.
23. Loomis WH, Namiki S, Ostrom RS, et al. Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation. J Biol Chem 2003; 278:4590.
24. Hashimoto K, Nishizaki T, Yoshizumi T, et al. Beneficial effect of FR167653 on cold ischemia/reperfusion injury in rat liver transplantation. Transplantation2000; 70: 1318.
25. Yamamoto H, Sugitani A, Kitada H, et al. Effect of FR167653 on pancreatic ischemia-reperfusion injury in dogs. Surgery 2001; 129: 309.24.
26. Li Z, Tran TT, Ma JY, et al. p38 alpha mitogen-αctivated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J Cardiovasc Pharmacol 2004; 44: 486.
27. Shiroto K, Otani H, Yamamoto F, et al. MK2-/- gene knockout mouse hearts carry anti-αpoptotic signal and are resistant to ischemia reperfusion injury. J Mol Cell Cardiol 2005; 38: 93.
28. Arita S, Nagai T, Ochiai M, et al. Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. Transplantation2002; 73: 7.
29. Kenmochi T, Miyamoto M, Une S, et al. Improved quality and yield of islets isolated from human pancreata using a two-step digestion method. Pancreas 2000; 20: 184.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 ( - Delta Delta C(T)) Method. Methods 2001; 25: 402.
31. Omori K, Valiente L, Orr C, et al. Improvement of human islet cryo-preservation by a p38 MAPK inhibitor. Am J Transplant2007; 7: 1224.
32. Tilney NL, Kusaka M, Pratschke J, et al. Chronic rejection. Transplant Proc 1998; 30: 1590.
33. Soares MP, Brouard S, Smith RN, et al. Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol Rev 2001; 184: 275.
34. Tanaka K, Shirasugi N, Inoue F. MCI-186 (free radical scavenger) induced prolonged survival of fully allogeneic cardiac grafts. Am J Transplant2004; 4: 527.
35. Koike N, Takeyoshi I, Ohki S, et al. Effects of adding P38 mitogen-αctivated protein-kinase inhibitor to celsior solution in canine heart transplantation from non-heart-beating donors. Transplantation2004; 77:286.
36. Hashimoto N, Takeyoshi I, Yoshinari D, et al. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to Euro-Collins solution on reperfusion injury in canine lung transplantation. Transplantation2002; 74: 320.
37. Kobayashi M, Takeyoshi I, Yoshinari D, et al. P38 mitogen-αctivated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery 2002; 131: 344.
38. Paraskevas S, Aikin R, Maysinger D, et al. Modulation of JNK and p38 stress activated protein kinases in isolated islets of Langerhans: Insulin as an autocrine survival signal. Ann Surg 2001; 233: 124.
39. NoguchiH,NakaiY,MatsumotoS,etal. Cell permeable peptideofJNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am J Transplant2005; 5: 1848.
40. Noguchi H, Nakai Y, Ueda M, et al. Activaation of c-Jun NH2-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitor. Diabetologia 2007; 50: 612.
41. Omori K, Shintaku J, Rawson J, et al. p38 mitogen activated protein kinase inhibitor improves the quality of cultured human islets. Xenotransplant 2007; 14: 420.
42. Paraskevas S, Aikin R, Maysinger D, et al. Activation and expression of ERK, JNK, and p38 MAP-kinases in isolated islets of Langerhans: Implications for cultured islet survival. FEBS Lett 1999; 455: 203.